Elicio Therapeutics Stock Price To Sales

ELTX Stock   5.09  0.10  2.00%   
Elicio Therapeutics fundamentals help investors to digest information that contributes to Elicio Therapeutics' financial success or failures. It also enables traders to predict the movement of Elicio Stock. The fundamental analysis module provides a way to measure Elicio Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elicio Therapeutics stock.
Last ReportedProjected for Next Year
Price To Sales Ratio 0.60  0.57 
Price To Sales Ratio is likely to drop to 0.57 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Elicio Therapeutics Company Price To Sales Analysis

Elicio Therapeutics' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Current Elicio Therapeutics Price To Sales

    
  0.57  
Most of Elicio Therapeutics' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elicio Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Elicio Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Elicio Therapeutics is extremely important. It helps to project a fair market value of Elicio Stock properly, considering its historical fundamentals such as Price To Sales. Since Elicio Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Elicio Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Elicio Therapeutics' interrelated accounts and indicators.
0.08-0.910.620.08-0.920.970.440.180.090.930.790.070.130.790.83-0.59
0.080.03-0.34-0.49-0.240.16-0.11-0.970.990.23-0.380.42-0.36-0.380.3-0.67
-0.910.03-0.82-0.420.96-0.91-0.14-0.280.0-0.74-0.860.21-0.3-0.86-0.880.65
0.62-0.34-0.820.73-0.70.64-0.010.5-0.260.460.86-0.720.780.860.49-0.31
0.08-0.49-0.420.73-0.270.18-0.60.51-0.44-0.20.39-0.850.60.390.210.07
-0.92-0.240.96-0.7-0.27-0.95-0.11-0.01-0.26-0.8-0.730.09-0.2-0.73-0.940.79
0.970.16-0.910.640.18-0.950.250.090.180.870.71-0.020.160.710.86-0.61
0.44-0.11-0.14-0.01-0.6-0.110.250.22-0.120.650.430.42-0.010.43-0.02-0.01
0.18-0.97-0.280.50.51-0.010.090.22-0.960.010.59-0.40.390.59-0.070.49
0.090.990.0-0.26-0.44-0.260.18-0.12-0.960.25-0.330.33-0.26-0.330.29-0.69
0.930.23-0.740.46-0.2-0.80.870.650.010.250.70.190.140.70.66-0.59
0.79-0.38-0.860.860.39-0.730.710.430.59-0.330.7-0.340.541.00.55-0.35
0.070.420.21-0.72-0.850.09-0.020.42-0.40.330.19-0.34-0.9-0.340.12-0.16
0.13-0.36-0.30.780.6-0.20.16-0.010.39-0.260.140.54-0.90.54-0.110.05
0.79-0.38-0.860.860.39-0.730.710.430.59-0.330.71.0-0.340.540.55-0.35
0.830.3-0.880.490.21-0.940.86-0.02-0.070.290.660.550.12-0.110.55-0.8
-0.59-0.670.65-0.310.070.79-0.61-0.010.49-0.69-0.59-0.35-0.160.05-0.35-0.8
Click cells to compare fundamentals

Elicio Price To Sales Historical Pattern

Today, most investors in Elicio Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Elicio Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Elicio Therapeutics price to sales as a starting point in their analysis.
   Elicio Therapeutics Price To Sales   
       Timeline  
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

Elicio Price To Sales Ratio

Price To Sales Ratio

0.57

At this time, Elicio Therapeutics' Price To Sales Ratio is fairly stable compared to the past year.

Elicio Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elicio Therapeutics' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elicio Therapeutics could also be used in its relative valuation, which is a method of valuing Elicio Therapeutics by comparing valuation metrics of similar companies.
Elicio Therapeutics is currently under evaluation in price to sales category among its peers.

Elicio Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Elicio Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Elicio Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

Elicio Fundamentals

About Elicio Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Elicio Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elicio Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elicio Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Elicio Stock Analysis

When running Elicio Therapeutics' price analysis, check to measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.